Cannabis derived products in novel foods & cosmetics. How to get them to the market? скачать в хорошем качестве

Cannabis derived products in novel foods & cosmetics. How to get them to the market?

Cannabidiol (CBD) has received a lot of attention globally because of its powerful anti-inflammatory, anticonvulsant, anti-anxiety and pain-relieving properties. As such, many companies are keen to seize opportunities to use it in animal feed, human food, food supplements and cosmetics. However, the regulatory landscape for CBD is complex, and its use in feed, food & cosmetics in the EU is far from straightforward. Learn about the regulatory status of CBD and how to legally sell your CBD-containing products in the EU. This podcast covers all you need to know about the regulatory challenges, claims and advertisement associated with CBD in the EU. In the EU, all novel food authorisations are generic, meaning that any company can sell that novel food if they meet the specification set out in the authorization. However, it is possible for an applicant to request data protection when they submit their dossier. Data protection only applies to proprietary information such as toxicology data. Data protection is granted for a period of 5 years & cannot be extended. During this period, only the authorization holder can sell the novel food in the EU. Any other company wanting to sell the same product would need to submit their own data to achieve their own authorisation. EU novel food authorisations do not require renewal. We also wanted to clarify that many countries set their own limits on the permitted content of THC & many have a zero-tolerance policy. The point we were trying to get across is that at EU level, the 0.02% THC limit refers to the content of THC in the plant itself, not the final food or ingredient.